Eye Clinic | |
1200 Winchester Dr, Sedalia, MO 65301-2467 | |
(660) 826-2642 | |
(660) 826-6748 |
Full Name | Eye Clinic |
---|---|
Type | Facility |
Speciality | Optometrist |
Location | 1200 Winchester Dr, Sedalia, Missouri |
Accepts Medicare Assignments | Does not participate in Medicare Program. The facility may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1770524522 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
152W00000X | Optometrist | (* (Not Available)) | Primary |
Mailing Address | Practice Location Address |
---|---|
Eye Clinic 1200 Winchester Dr, Sedalia, MO 65301-2467 Ph: (660) 826-2642 | Eye Clinic 1200 Winchester Dr, Sedalia, MO 65301-2467 Ph: (660) 826-2642 |
News Archive
Neuralstem, Inc. announced that safety results from the first 12 patients with amyotrophic lateral sclerosis (ALS or Lou Gehrig's disease) to receive its stem cells were reported online in the peer-reviewed publication, Stem Cells, on March 13th.
Coalition America announced today that it has completed the acquisition of the assets of OPN eHealth Services, Ltd., formerly known as Ohio Provider Network (OPN), an Ohio based provider network. Coalition America will offer its clients immediate access to these providers through its comprehensive cost containment solutions.
Estrogen and progesterone hormones in birth control do not influence the effectiveness of highly active antiretroviral therapy (HAART), which is used to treat HIV infection, according to researchers from the Johns Hopkins Bloomberg School of Public Health and other institutions. The study is published in the May 1, 2005, issue of the American Journal of Epidemiology.
In 2005, the Scandinavian Prostate Cancer Group Study 4 (SPCG-4) reported that radical prostatectomy improved prostate cancer survival compared with watchful waiting after a median of 8.2 years of follow-up.
Keryx Biopharmaceuticals, Inc. (the "Company") today announced that an article entitled "Clinical and Translational Studies of a Phase II Trial of the Novel Oral Akt Inhibitor Perifosine in Relapsed or Relapsed/Refractory Waldenstrom's Macroglobulinemia," reporting Phase 2 data demonstrating the single agent activity of KRX-0401 (Perifosine) for the treatment of advanced Waldenstrom's Macroglobulinemia ("Waldenstrom's"), will appear in the February 1, 2010 issue of Clinical Cancer Research.
› Verified 1 days ago
Dr Barbara Knight Od Pc Optometrist Medicare: Not Enrolled in Medicare Practice Location: 316 W 4th St, Sedalia, MO 65301 Phone: 660-827-4120 Fax: 660-827-1525 | |
Eyecare Specialties Optometrist Medicare: Not Enrolled in Medicare Practice Location: 3403 W 10th St, Sedalia, MO 65301 Phone: 660-826-6161 Fax: 660-826-8197 | |
Dr. Desmon Paige Carl, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 1200 Winchester Dr, Sedalia, MO 65301 Phone: 660-826-2642 | |
Dr. Barbara Louise Knight, OD Optometrist Medicare: Not Enrolled in Medicare Practice Location: 316 W 4th St, Sedalia, MO 65301 Phone: 660-827-4120 Fax: 660-827-1525 | |
Brett H Liesemeyer, OD Optometrist Medicare: Accepting Medicare Assignments Practice Location: 3403 W 10th St, Sedalia, MO 65301 Phone: 660-826-6161 Fax: 660-826-8197 | |
Deanna Lynn Nelson, O.D. Optometrist Medicare: Not Enrolled in Medicare Practice Location: 1400 S Limit Ave, Space 75 State Fair Shopping Center, Sedalia, MO 65301 Phone: 660-827-3140 Fax: 660-827-5204 | |
Dr. Kevin Kyle Edward Carl, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 1200 Winchester Dr, Sedalia, MO 65301 Phone: 660-826-2642 |